neuromotion
PrivateLast Round
Series A
Apr 7, 2026
Total Funding Raised
$19.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
neuromotion operates in Healthcare & Life Sciences and is based in Berlin. Its latest recorded funding round was a Series A round in April 2026.
neuromotion is a neurotechnology company that develops, produces, and commercializes research-grade neurotechnology solutions and engages in early-stage venture building.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
neuromotion Comparables
Compare neuromotion with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Brain Products GmbH | 92% | |
| g.tec medical engineering | 86% | |
| mBrainTrain | 85% |
For institutional investors. Book with your work email.
neuromotion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 7, 2026 | ||||
| Grant | Dec 19, 2022 | ||||
| Seed | Nov 8, 2021 |
For institutional investors. Book with your work email.
neuromotion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series A |
| European Innovation Council Accelerator | Grant |
| European Commission | Grant |
| Wallonie Entreprendre | Series A, Seed |
| White Fund | Series A |
| Invest.BW | Series A |
| Invest BW Innovationsförderung | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
$11M round led by eic-ec-europa and Teampact Ventures.
- Dec 19, 2022
Secured $2.65M from the European Innovation Council Accelerator.
For institutional investors. Book with your work email.
neuromotion Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about neuromotion's valuation, stock price, and market status.
Is neuromotion a public or private company?
neuromotion is a private company.
What is the current stock price of neuromotion?
neuromotion is a private company, so its shares have no public market price. Caplight tracks neuromotion's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is neuromotion worth (valuation)?
Valuation information for neuromotion is not publicly available.
Can I buy neuromotion stock?
neuromotion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was neuromotion's last funding round?
neuromotion's most recent funding round was Series A on April 7, 2026.
Who are the main investors in neuromotion?
Key investors in neuromotion include European Innovation Council Fund, European Innovation Council Accelerator, White Fund, Invest BW Innovationsförderung, Teampact Ventures.
Will neuromotion IPO soon?
No public IPO plans have been announced for neuromotion.
How can I track neuromotion secondary market activity?
Caplight tracks bids, offers, and trades in neuromotion's shares on secondary markets.